Bioceltix SA GPW:BCX:
ITS SHAREHOLDERS COMPLETE ABB PROCESS
SHARE OFFER INCREASED FROM 577,785 TO 727,785 DUE TO HIGH DEMAND
UNIT SALE PRICE OF SHARES SET AT 87.00 PLN
Bioceltix's Shareholders Complete ABB Process
Earlier from Bioceltix
Later from Bioceltix
- Bioceltix Says EGM To Vote On Increase of Share Capital Via Issue Of O Series Shares
- TFI PZU Funds Up Stake In Bioceltix To 15.75%
- Bioceltix Q3 Net Loss At 4.4 Mln Zlotys
- Bioceltix Gets GMP Certificate For Wroclaw Veterinary Medicine Facility
- BCX: Pioneering stem cell therapies for pets, with proven efficacy and major market expansion plans
Follow Bioceltix into a list and get an email when it puts out news.
Follow Bioceltix